We are live on
!
Find out more
ECM
ExodusPoint Capital Management Portfolio holdings
AUM
$12.6B
1-Year Est. Return
30.13%
This Fund
S&P 500
This Quarter
Est. Return
+28.05%
1 Year Est. Return
+30.13%
3 Year Est. Return
+85.63%
5 Year Est. Return
+104.04%
10 Year Est. Return
–
AUM
$10.3B
AUM Growth
+$5.25B
(+105%)
Cap. Flow
+$4.62B
Cap. Flow
% of AUM
45%
Top 10 Holdings %
Top 10 Hldgs %
41.75%
Holding
2,600
New
918
Increased
493
Reduced
472
Closed
701
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$353M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$256M |
| 4 |
Alibaba
BABA
|
+$189M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$82M |
| 2 |
Generac Holdings
GNRC
|
+$33.7M |
| 3 |
Pool Corp
POOL
|
+$32.5M |
| 4 |
Keurig Dr Pepper
KDP
|
+$31M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.17% |
| 2 | Consumer Discretionary | 10.74% |
| 3 | Healthcare | 4.99% |
| 4 | Industrials | 4.03% |
| 5 | Financials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Nektar Therapeutics
NKTR
$2.53B
| $281K | ﹤0.01% |
1,103
-2,264
| -67% | -$585K |
|
1577
CryoPort
CYRX
$751M
| $280K | ﹤0.01% |
+6,391
| New | +$304K |
|
|
SY
1578
So-Young International
SY
$228M
| $280K | ﹤0.01% |
+25,203
| New | +$311K |
|
|
MASI
1579
DELISTED
Masimo
MASI
| $279K | ﹤0.01% |
1,040
-158
| -13% | -$39.4K |
|
|
HSKA
1580
DELISTED
Heska Corp
HSKA
| $279K | ﹤0.01% |
+1,913
| New | +$238K |
|
1581
Adient
ADNT
$1.44B
| $278K | ﹤0.01% |
+7,996
| New | +$225K |
|
|
MRC
1582
DELISTED
MRC Global
MRC
| $278K | ﹤0.01% |
41,999
+17,849
| +74% | +$98.4K |
|
|
HIBB
1583
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $278K | ﹤0.01% |
+6,018
| New | +$269K |
|
1584
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $277K | ﹤0.01% |
56,125
+45,212
| +414% | +$174K |
|
1585
Visteon
VC
$2.8B
| $275K | ﹤0.01% |
2,192
-2,209
| -50% | -$233K |
|
1586
CytomX Therapeutics
CTMX
$750M
| $273K | ﹤0.01% |
41,728
+12,365
| +42% | +$88.3K |
|
1587
Napco Security Technologies
NSSC
$1.43B
| $273K | ﹤0.01% |
+20,818
| New | +$281K |
|
|
ALTR
1588
DELISTED
Altair Engineering Inc
ALTR
| $273K | ﹤0.01% |
4,696
-4,371
| -48% | -$220K |
|
|
PTR
1589
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $273K | ﹤0.01% |
8,871
+833
| +10% | +$25.5K |
|
1590
Curis
CRIS
$7.13M
| $272K | ﹤0.01% |
83
+52
| +168% | +$62.4K |
|
1591
ResMed
RMD
$31.9B
| $272K | ﹤0.01% |
+1,278
| New | +$255K |
|
1592
DXC Technology
DXC
$1.74B
| $271K | ﹤0.01% |
10,528
-24,216
| -70% | -$517K |
|
|
NOACU
1593
DELISTED
Natural Order Acquisition Corp. Unit
NOACU
| $271K | ﹤0.01% |
+25,000
| New | +$267K |
|
1594
Inovio Pharmaceuticals
INO
$76.1M
| $268K | ﹤0.01% |
+2,521
| New | +$336K |
|
|
FTCVU
1595
DELISTED
FinTech Acquisition Corp. V Unit
FTCVU
| $267K | ﹤0.01% |
+25,000
| New | +$261K |
|
|
CLDT
1596
Chatham Lodging
CLDT
$580M
| $266K | ﹤0.01% |
+24,668
| New | +$236K |
|
1597
Korea Electric Power
KEP
$15.7B
| $266K | ﹤0.01% |
+21,643
| New | +$214K |
|
|
LONA
1598
LeonaBio Inc
LONA
$70.5M
| $264K | ﹤0.01% |
770
-5,924
| -88% | -$1.4M |
|
1599
Global X Autonomous & Electric Vehicles ETF
DRIV
$392M
| $264K | ﹤0.01% |
+11,000
| New | +$225K |
|
1600
DaVita
DVA
$11.7B
| $264K | ﹤0.01% |
2,246
-21,064
| -90% | -$2.15M |
|
Similar funds
LPC
IWC
EIG
IMPI
ZIM
ZIG
ACA
WANY
ExodusPoint Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, ExodusPoint Capital Management held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
ExodusPoint Capital Management deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.
- ExodusPoint Capital Management's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
- ExodusPoint Capital Management added most to Amazon in Q4 2020, an estimated $353M increase.
- ExodusPoint Capital Management's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
- ExodusPoint Capital Management fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
- ExodusPoint Capital Management's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
- ExodusPoint Capital Management opened 918 new positions and closed 701 in Q4 2020.
- ExodusPoint Capital Management's portfolio value rose 105% quarter-over-quarter to $10.3B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.